Old Web
English
Sign In
Acemap
>
Paper
>
A Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Essential Thrombocythemia (ET)
A Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Essential Thrombocythemia (ET)
2021
Francesca Palandri
Nicola Vianelli
David M. Ross
Tara Cochrane
Steven W. Lane
Stephen Larsen
Aaron T. Gerds
Anna B. Halpern
Jake Shortt
James M. Rossetti
Kristen Pettit
Amber Jones
Jennifer Peppe
Georges Natsoulis
Willis H. Navarro
Wan-Jen Hong
William Stevenson
Claire N. Harrison
Moshe Talpaz
Hugh Y. Rienhoff
Keywords:
Pharmacology
lsd1 inhibitor img 7289
Phases of clinical research
Medicine
Essential thrombocythemia
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]